Inhibitors of the Inducible Nitric Oxide Synthase as Antiglioma Agents †
by
, , , ,
Cristina Maccallini
*, 
Marialucia Gallorini
,
Pasquale Amoia
,
Alessandra Ammazzalorso
,
Barbara De Filippis
,
Marialuigia Fantacuzzi
,
Letizia Giampietro
,
Amelia Cataldi
and
Rosa Amoroso
Department of Pharmacy, University “G. d’Annunzio” of Chieti-Pescara, via dei Vestini, 31, 66100 Chieti, Italy
*
Author to whom correspondence should be addressed.
†
Presented at the 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery, Barcelona, Spain, 15–17 May 2019.
Proceedings 2019, 22(1), 52; https://doi.org/10.3390/proceedings2019022052
Published: 8 August 2019
(This article belongs to the Proceedings of The 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery)
Malignant gliomas are highly lethal brain tumors with poor prognosis for patients. The current treatment of glioma consists of maximal surgical resection of the tumor, followed by concurrent chemotherapy (temozolomide, TMZ) and radiation. However, chemotherapy resistance is a major cause of treatment failure.
In general, high levels of reactive oxygen species (ROS) and reactive nitrogen species (RNS) are highly involved in the malignancy of gliomas as well as in chemoresistance, due to the activation of different signaling mediators. In this context, the dysregulated production of the free radical nitric oxide (NO) by inducible nitric oxide synthase (iNOS) plays a recognized role, and NO inhibition can be considered an emerging therapeutic possibility to treat gliomas [1].
From the development of the acetamidine 1400 W, we recently identified a new small potent molecule, able to selectively inhibit iNOS in rat glioma cells without interacting with the constitutive NOS isoforms [2]. This agent compromises the adaptive responses in glioma cells involved in chemoresistance, enhancing the effects of TMZ [3]. As part of this ongoing project, a new set of acetamidines was synthesized, and the biological results of these molecules will be discussed from a medicinal chemistry viewpoint.
References
- Eyler, C.E.; Wu, Q.; Yan, K.; MacSwords, J. M.; Chandler-Militello, D.; Misuraca, K. L.; Lathia, J.D.; Forrester, M.T.; Lee, J.; Stamler, J.S.; et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 2011, 146, 53–66. [Google Scholar] [CrossRef] [PubMed]
- Maccallini, C.; Di Matteo, M.; Gallorini, M.; Montagnani, M.; Graziani, V.; Ammazzalorso, A.; Amoia, P.; De Filippis, B.; Silvestre, S.D.; Fantacuzzi, M.; et al. Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma. Eur. J. Med. Chem. 2018, 152, 53–64. [Google Scholar] [CrossRef] [PubMed]
- Gallorini, M.; Maccallini, C.; Ammazzalorso, A.; Amoia, P.; De Filippis, B.; Fantacuzzi, M.; Giampietro, L.; Cataldi, A.; Amoroso, R. The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage in vitro. Int. J. Mol. Sci. 2019, 20, 495. [Google Scholar] [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Maccallini, C.; Gallorini, M.; Amoia, P.; Ammazzalorso, A.; Filippis, B.D.; Fantacuzzi, M.; Giampietro, L.; Cataldi, A.; Amoroso, R. Inhibitors of the Inducible Nitric Oxide Synthase as Antiglioma Agents. Proceedings 2019, 22, 52. https://doi.org/10.3390/proceedings2019022052
AMA Style
Maccallini C, Gallorini M, Amoia P, Ammazzalorso A, Filippis BD, Fantacuzzi M, Giampietro L, Cataldi A, Amoroso R. Inhibitors of the Inducible Nitric Oxide Synthase as Antiglioma Agents. Proceedings. 2019; 22(1):52. https://doi.org/10.3390/proceedings2019022052
Chicago/Turabian StyleMaccallini, Cristina, Marialucia Gallorini, Pasquale Amoia, Alessandra Ammazzalorso, Barbara De Filippis, Marialuigia Fantacuzzi, Letizia Giampietro, Amelia Cataldi, and Rosa Amoroso. 2019. "Inhibitors of the Inducible Nitric Oxide Synthase as Antiglioma Agents" Proceedings 22, no. 1: 52. https://doi.org/10.3390/proceedings2019022052
